172 related articles for article (PubMed ID: 3546546)
1. In vitro and in vivo activities of ofloxacin against Mycobacterium leprae infection induced in mice.
Saito H; Tomioka H; Nagashima K
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):560-2. PubMed ID: 3546546
[TBL] [Abstract][Full Text] [Related]
2. Activity of ofloxacin against Mycobacterium leprae in the mouse.
Grosset JH; Guelpa-Lauras CC; Perani EG; Beoletto C
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):259-64. PubMed ID: 3045223
[TBL] [Abstract][Full Text] [Related]
3. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
Dhople AM; Ibanez MA
Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
[TBL] [Abstract][Full Text] [Related]
4. Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice.
Franzblau SG; Parrilla ML; Chan GP
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):66-9. PubMed ID: 8392100
[TBL] [Abstract][Full Text] [Related]
5. In vivo activities of novel benzoxazinorifamycins against Mycobacterium leprae.
Dhople AM; Ibanez MA
Indian J Lepr; 1995; 67(4):375-82. PubMed ID: 8849914
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
Ji B; Perani EG; Petinon C; Grosset JH
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
[TBL] [Abstract][Full Text] [Related]
7. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
[TBL] [Abstract][Full Text] [Related]
8. Newer drugs in leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
[TBL] [Abstract][Full Text] [Related]
9. Screening of drugs for activity against Mycobacterium leprae.
Baohong J; Matsuo Y; Colston MJ
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576
[No Abstract] [Full Text] [Related]
10. An experimental study to evaluate the bactericidal activity of ofloxacin against an established Mycobacterium leprae infection.
Banerjee DK; McDermott-Lancaster RD
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):410-5. PubMed ID: 1474279
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
Dhople AM; Dimova V
Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
[TBL] [Abstract][Full Text] [Related]
13. Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
Pattyn SR
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):613-7. PubMed ID: 1666402
[TBL] [Abstract][Full Text] [Related]
14. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
Dhople AM; Ibanez MA; Gardner GD
Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
[TBL] [Abstract][Full Text] [Related]
15. In vivo susceptibility of Mycobacterium leprae to sitafloxacin (DU-6859a), either singly or in combination with rifampicin analogues.
Dhople AM; Namba K
Int J Antimicrob Agents; 2003 Mar; 21(3):251-5. PubMed ID: 12636987
[TBL] [Abstract][Full Text] [Related]
16. Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test.
McDermott-Lancaster RD; Banerjee DK
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):605-8. PubMed ID: 8151193
[TBL] [Abstract][Full Text] [Related]
17. [Action of desoxyfructo-serotonin on Mycobacterium leprae. Results of inoculation of human biopsy specimens in the mouse after a year of treatment].
Ferracci C; Baquillon G; Pattyn SR
Acta Leprol; 1983; 1(4):233-5. PubMed ID: 6377799
[TBL] [Abstract][Full Text] [Related]
18. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
Ganapati R; Revankar CR; Pai VV; Kingsley S
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
[No Abstract] [Full Text] [Related]
19. Single-dose treatment for paucibacillary leprosy; field implications.
Revankar CR; Pai VV; Samy MS; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
[No Abstract] [Full Text] [Related]
20. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.
Ji B; Sow S; Perani E; Lienhardt C; Diderot V; Grosset J
Antimicrob Agents Chemother; 1998 May; 42(5):1115-20. PubMed ID: 9593137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
